Yesterday, March 7, 2016, 102 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $19.20 to $9,281,506.50.

Highlighted Stocks Traded by Insiders:

Medivation (MDVN) - FREE Research Report

Bierly Rick, who is Chief Financial Officer at Medivation, sold 2,998 shares at $40.00 on March 7, 2016. Following this transaction, the Chief Financial Officer owned 39,084 shares meaning that the stake was reduced by 7.12% with the 2,998-share transaction.

Hirmand Mohammad, who is Interim Chief Medical Officer at Medivation, sold 1,525 shares at $41.10 on March 7, 2016. Following this transaction, the Interim Chief Medical Officer owned 39,342 shares meaning that the stake was reduced by 3.73% with the 1,525-share transaction.

The shares most recently traded at $39.78, down $1.32, or 3.33% since the insider transaction. Historical insider transactions for Medivation go as follows:

  • 4-Week # shares sold: 6,350
  • 12-Week # shares sold: 9,415
  • 24-Week # shares sold: 21,672

The average volume for Medivation has been 2.2 million shares per day over the past 30 days. Medivation has a market cap of $6.6 billion and is part of the health care sector and drugs industry. Shares are down 15.72% year-to-date as of the close of trading on Monday.

Medivation, Inc., a biopharmaceutical company, focuses on the development and commercialization of medical therapies to treat serious diseases in the United States. It offers XTANDI for the treatment of post-chemotherapy metastatic castration-resistant prostate cancer (CRPC) patients. The company has a P/E ratio of 27.5. Currently, there are 9 analysts who rate Medivation a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MDVN - FREE

TheStreet Quant Ratings rates Medivation as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and disappointing return on equity. Get the full Medivation Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Salesforce.com (CRM) - FREE Research Report

Benioff Marc, who is Chairman of the Board & CEO at Salesforce.com, sold 37,500 shares at $70.52 on March 7, 2016. Following this transaction, the Chairman of the Board & CEO owned 36.2 million shares meaning that the stake was reduced by 0.1% with the 37,500-share transaction.

The shares most recently traded at $70.35, down $0.17, or 0.25% since the insider transaction. Historical insider transactions for Salesforce.com go as follows:

  • 4-Week # shares sold: 176,464
  • 12-Week # shares sold: 725,249
  • 24-Week # shares sold: 1.4 million

The average volume for Salesforce.com has been 5.9 million shares per day over the past 30 days. Salesforce.com has a market cap of $47.2 billion and is part of the technology sector and computer software & services industry. Shares are down 10.09% year-to-date as of the close of trading on Monday.

salesforce.com, inc. provides enterprise cloud computing solutions, with a focus on customer relationship management to various businesses and industries worldwide. Currently, there are 23 analysts who rate Salesforce.com a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CRM - FREE

TheStreet Quant Ratings rates Salesforce.com as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and impressive record of earnings per share growth. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. Get the full Salesforce.com Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

MobileIron (MOBL) - FREE Research Report

Mainz Barry, who is President and CEO at MobileIron, bought 51,200 shares at $3.90 on March 7, 2016. Following this transaction, the President and CEO owned 811,200 shares meaning that the stake was boosted by 6.74% with the 51,200-share transaction.

The shares most recently traded at $4.13, up $0.23, or 5.49% since the insider transaction. Historical insider transactions for MobileIron go as follows:

  • 4-Week # shares sold: 2,487
  • 12-Week # shares sold: 2,487
  • 24-Week # shares bought: 20,000
  • 24-Week # shares sold: 2,487

The average volume for MobileIron has been 327,000 shares per day over the past 30 days. MobileIron has a market cap of $327.9 million and is part of the technology sector and computer software & services industry. Shares are up 11.91% year-to-date as of the close of trading on Monday.

MobileIron, Inc. provides a purpose-built mobile IT platform that enables enterprises to secure and manage mobile applications, content, and devices while providing their employees with device choice, privacy, and a native user experience. Currently, there are 5 analysts who rate MobileIron a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MOBL - FREE

TheStreet Quant Ratings rates MobileIron as a sell. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full MobileIron Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.